Mettler-Toledo International Inc. (NYSE:MTD) has been assigned a consensus rating of “Hold” from the thirteen ratings firms that are covering the company, MarketBeat reports. Ten analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $624.33.

A number of equities research analysts have issued reports on the company. Zacks Investment Research lowered Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Tuesday, October 16th. ValuEngine upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Friday, November 16th. UBS Group assumed coverage on Mettler-Toledo International in a research note on Tuesday, October 9th. They issued a “neutral” rating and a $625.00 price target for the company. Finally, Morgan Stanley increased their price target on Mettler-Toledo International from $529.00 to $572.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 10th.

Mettler-Toledo International stock traded down $18.57 during trading on Thursday, reaching $610.10. The company had a trading volume of 333,142 shares, compared to its average volume of 184,753. Mettler-Toledo International has a 52 week low of $521.79 and a 52 week high of $697.26. The stock has a market cap of $15.75 billion, a P/E ratio of 34.72, a P/E/G ratio of 2.44 and a beta of 1.20. The company has a debt-to-equity ratio of 1.86, a quick ratio of 1.00 and a current ratio of 1.39.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 8th. The medical instruments supplier reported $5.12 EPS for the quarter, topping the Zacks’ consensus estimate of $4.99 by $0.13. Mettler-Toledo International had a return on equity of 93.15% and a net margin of 14.10%. The company had revenue of $734.85 million for the quarter, compared to analysts’ expectations of $738.23 million. During the same period last year, the firm earned $4.36 EPS. Mettler-Toledo International’s revenue for the quarter was up 5.2% compared to the same quarter last year. Analysts predict that Mettler-Toledo International will post 20.23 EPS for the current year.

In other news, Director Hans Ulrich Maerki sold 3,384 shares of the firm’s stock in a transaction dated Tuesday, November 27th. The stock was sold at an average price of $605.00, for a total transaction of $2,047,320.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider La Guerroniere Marc De sold 6,245 shares of the firm’s stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $642.79, for a total value of $4,014,223.55. Following the transaction, the insider now owns 6,245 shares of the company’s stock, valued at approximately $4,014,223.55. The disclosure for this sale can be found here. Insiders sold a total of 31,871 shares of company stock valued at $19,575,275 in the last quarter. 4.80% of the stock is currently owned by company insiders.

Several institutional investors have recently modified their holdings of MTD. WCM Investment Management CA purchased a new position in shares of Mettler-Toledo International during the second quarter valued at about $527,205,000. Moneta Group Investment Advisors LLC purchased a new position in shares of Mettler-Toledo International during the second quarter valued at about $110,000. American Century Companies Inc. purchased a new position in shares of Mettler-Toledo International during the second quarter valued at about $33,951,000. Credit Suisse AG grew its position in shares of Mettler-Toledo International by 22.6% during the third quarter. Credit Suisse AG now owns 303,768 shares of the medical instruments supplier’s stock valued at $184,990,000 after purchasing an additional 55,979 shares in the last quarter. Finally, Putnam Investments LLC grew its position in shares of Mettler-Toledo International by 27.0% during the third quarter. Putnam Investments LLC now owns 236,651 shares of the medical instruments supplier’s stock valued at $144,116,000 after purchasing an additional 50,261 shares in the last quarter. Hedge funds and other institutional investors own 93.80% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.

Featured Story: Retained Earnings

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.